Jaguar Health, Inc. (JAGX) is a publicly traded Healthcare sector company. As of May 21, 2026, JAGX trades at $3.51 with a market cap of $1.90M and a P/E ratio of -0.16. JAGX moved +0.00% today. Year to date, JAGX is -88.80%; over the trailing twelve months it is -98.02%. Its 52-week range spans $2.53 to $1,121.59. Rallies surfaces JAGX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own JAGX include Two Sigma. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Jaguar Health, Inc..
| Metric | Value |
|---|---|
| Price | $3.51 |
| Market Cap | $1.90M |
| P/E Ratio | -0.16 |
| EPS | $-22.97 |
| Dividend Yield | 0.00% |
| 52-Week High | $1,121.59 |
| 52-Week Low | $2.53 |
| Volume | 29.76K |
| Avg Volume | 0 |
| Revenue (TTM) | $11.51M |
| Net Income | $-54.00M |
| Gross Margin | 67.21% |
JAGX analyst coverage data. Average price target: $0.00.